Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study
Jared Silver, Elizabeth Packnett, Julie Park, Arijita Deb · 2023
Read Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study by Jared Silver, Elizabeth Packnett, Julie Park, Arijita Deb (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10709958.txt.
Description
Jared Silver and three co-authors map how biologic drugs are used for a stubborn sinus condition in the United States, in a 2023 claims study. The condition pairs long-term sinus inflammation with nasal polyps. Several biologics are approved as add-on care. The team used a large insurance claims database to find nearly six thousand adults with the condition. They tracked care over about two years and compared users and non-users of the drugs.
About one in ten patients used a biologic in the follow-up year. Users were far more likely to have asthma, which alone raised the odds more than fivefold. Steroid pill use was also higher among users. Most surgery patients who used a biologic started it before their operation. The authors say the pattern marks patients with high unmet need. Such signs could help clinics spot good candidates sooner.
Catalog record
| CREATOR | Jared Silver, Elizabeth Packnett, Julie Park, Arijita Deb |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |